In plans announced today Rösler is also seeking to drastically cut the price of drugs already on the market by forcing manufacturers to agree them with the German Treasury.
.../...
His plans would also require pharma to demonstrate how new drugs benefit patients and how they build on existing treatments for the same condition.
Más
viernes, 9 de abril de 2010
Alemania: Rechazo a prácticas monopolísticas de la industria farmacéutica...
Etiquetas:
Alemania,
Comunicación,
Precio
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario